IHP news 521: Access to medicines

By on May 10, 2019

NBC – Generic HIV prevention drug coming in 2020, Gilead says

https://www.nbcnews.com/feature/nbc-out/generic-hiv-prevention-drug-coming-2020-gilead-says-n1003391

Following a campaign by activists, Gilead announced a generic version of Truvada, or PrEP, will be available next September, a year earlier than expected.”

BMJ – Indian campaigners ask government to stop relying on handouts of bedaquiline to ensure supply

https://www.bmj.com/content/365/bmj.l2140

Health and patients’ rights groups have asked India’s health ministry to stop depending on donations of bedaquiline from Johnson and Johnson to treat patients with multidrug resistant tuberculosis (MDR-TB) and instead use its own funds to procure the drug. In a letter sent to the health ministry last week, the All India Drug Action Network (AIDAN), a consortium of physicians and health activists, and other groups said dependence on “piecemeal donations” threatened the sustainability and predictability of the government’s plan to treat patients with MDR-TB. They have asked the government to phase out donated bedaquiline and find and treat all patients in India eligible for the bedaquiline based regimen through its domestic budget….”

And a quick link on transparency in the US:

Stat – Drug makers will have to include prices in TV ads as soon as this summer

Leave a reply
Print Friendly, PDF & Email